Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Lucas Anderson

Orthopaedic Surgery Coeur D Alene, ID Medical Doctor

NPI 1073603692 CMS profile 1340981

2003 Kootenai Health Way, Coeur D Alene, ID 83814

Open in the dashboard

General payments

$242,986

209 records reported · program years 2019–2025

Research payments

$20,217

Paid to them · 4 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$232,063 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Lucas Anderson of Coeur D Alene, ID is reported in the CMS Open Payments database as having received $242,986 across 209 general payments and $20,217 in research payments paid to them. Separately, studies naming them as principal investigator received $232,063 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $24,536 38
2024 General $122,245 56
2023 General $49,770 45
2023 Research $4,817 2
2022 General $21,542 23
2022 Research $15,400 2
2021 General $9,852 14
2020 General $6,414 6
2019 General $8,626 27

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lucas Anderson
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Lucas Anderson were reported at $24,536. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Lucas Anderson Orthopaedic Surgery median Middle half National median
2019 $8,626 $644 $140–$2,844 $163
2020 $6,414 $312 $75–$1,860 $114
2021 $9,852 $520 $117–$2,495 $132
2022 $21,542 $598 $128–$2,731 $149
2023 $49,770 $461 $128–$2,264 $160
2024 $122,245 $497 $134–$2,475 $164
2025 $24,536 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medacta USA, Inc. $167,851 166 payments
  2. Zimmer Biomet Holdings, Inc. $66,709 4 payments
  3. Ethicon Endo-Surgery Inc. $7,140 1 payment
  4. Stryker Corporation $895 28 payments
  5. Smith+Nephew, Inc. $136 4 payments
  6. Innovation Technologies Inc $112 1 payment
  7. ConvaTec Inc. $56 1 payment
  8. DePuy Synthes Sales Inc. $54 2 payments
  9. Ethicon US, LLC $33 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $138,565 37 payments
  2. Acquisitions $45,937 1 payment
  3. Travel and Lodging $31,914 54 payments
  4. Royalty or License $19,907 1 payment
  5. Food and Beverage $6,662 116 payments
Products named General payments · program years 2019–2025
  1. Mpact Acetabular System $23,939 4 payments
  2. MPACT Hip $21,757 15 payments
  3. GMK Sphere Revision System $19,773 10 payments
  4. AMISTEM $17,845 23 payments
  5. GMK SPHERE $13,867 31 payments
  6. AMIStem H Femoral Stems $10,111 8 payments
  7. Mpact Orthopedics/Orthopedic Surgery $8,872 5 payments
  8. STRATAFIX $7,140 1 payment
  9. DERMABOND PRINEO $7,140 1 payment
  10. MONOCRYL $7,140 1 payment
  11. Other $29,324 116 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medacta USA, Inc. $20,217 4 payments

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

68

Median for Orthopedic Surgery: 203

Drug cost

$789

Median for Orthopedic Surgery: $1,433

Branded share of claims

25%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 28 $580
Sodium Chloride 0.9 % Sodium Chloride Brand 17 $105
Meloxicam Generic 23 $104

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 45 billing codes

Paid by Medicare

$155,855

Medicare's payments for the services billed

Medicare patients

230

Average age 73

Services billed

537

134 women, 96 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 70%
Depression 41%
Diabetes 32%
Ischemic heart disease 23%
Chronic kidney disease 23%
Osteoporosis 18%
Heart failure 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

213 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Idaho

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record